Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |